Merck continues to look at countries with emerging markets and promising drug discovery capabilities in its bid to find good drug candidates to populate its pipeline. Its latest agreement with Chennai, India-based Orchid Chemicals and Pharmaceuticals is for the discovery and development of anti-infectives.